Research News and Research

RSS

GOP's 'repeal health law' strategy may backfire in general election

Politico reports that several goals of Republicans -- including the repeal of the health care law -- "put them at odds with the majority of voters, according to a new survey by Resurgent Republic," a nonprofit polling and research group established by "GOP operative" Ed Gillespie to assist conservatives and Republicans.

6 May 2010

Book excerpt -- Landmark: The Inside Story of America's New Health Care Law and What It Means for Us All

Kaiser Health News looks at sections of a new book, Landmark: The Inside Story of America's New Health Care Law and What It Means for Us All, in which the staff of The Washington Post writes about various provisions of the new health law.

6 May 2010

DexCom first-quarter product revenue up 153%

DexCom, Inc. today reported its unaudited financial results for the quarter ended March 31, 2010.

6 May 2010

Study finds medical homes help lower health care costs, maintain quality

Kaiser Health News: "Some health policy experts and clinicians have long maintained that, in the effort to reduce health care costs and improve patient outcomes, there's no place like (a medical) home. A new study in the May issue of the journal Health Affairs seems to validate that notion. Medical homes — where primary care doctors are held responsible for coordinating care for individual patients - are seen as a model for lowering costs without sacrificing quality.

6 May 2010

Cardiogenesis reports 13% increase in first-quarter 2010 revenue

Cardiogenesis Corporation, a leading developer of surgical products used in the treatment of cardiac patients suffering from severe angina, today reported financial results for its first quarter ended March 31, 2010.

6 May 2010

African lawmakers appeal for U.N. resolution banning female genital mutilation

"The cutting or removal of young girls' and women's clitoris and/or labia affects some 120 to 140 million women ... mostly in Africa and the Middle East, according to the World Health Organisation," Agence France-Presse writes.

6 May 2010

Allos Therapeutics reports net loss of $20.5 million for first-quarter 2010

Allos Therapeutics, Inc. today reported financial results for the first quarter ended March 31, 2010.

6 May 2010

New research suggests tPA can act as neuroprotectant against stroke

New research on the properties of the clot-busting stroke drug tPA (tissue-type plasminogen activator) suggests that tPA can act as a neuroprotectant and may form the keystone of an adaptive response to a reduction in blood flow.

6 May 2010

FDA approves Provenge for treating men with advanced prostate cancer

The US Food and Drug Administration has approved a new 'cancer vaccine' for treating men with advanced prostate cancer.

6 May 2010

Democrat endorses GOP plan on hospital price disclosure

The Hill: Rep. Gene Green, D-Texas, is endorsing two Republican plans to require hospitals disclose their prices while other Democrats are pushing a much broader bill in the House Energy and Commerce Committee. Green "hopes to bring other Democrats with him, arguing a scaled-down approach stands a better chance of becoming law than the Democratic proposal, which would apply to all healthcare providers, including hospitals, physicians, pharmacies, drug makers and insurers."

6 May 2010

New test indicates bone marrow cell therapy may benefit MS patients

A groundbreaking trial to test bone marrow stem cell therapy with a small group of patients with multiple sclerosis (MS) has been shown to have possible benefits for the treatment of the disease.

6 May 2010

Vaccinogen chooses Clinipace Worldwide to manage pivotal phase 3b confirmatory trial for OncoVAX

Clinipace Worldwide, a global full-service clinical research organization (CRO), announced today that Vaccinogen, a biotechnology company with more than three decades experience researching how to combat cancer using the body's own immune system, has selected the company to manage a pivotal phase 3b confirmatory trial for OncoVAX in the treatment of Stage II Colon Cancer.

6 May 2010

United BioSource Corporation acquires Abt Bio-Pharma Solutions

Abt Associates announced today the sale of its wholly-owned subsidiary Abt Bio-Pharma Solutions, Inc. to United BioSource Corporation, a global scientific and medical affairs organization that partners with life science companies to develop and commercialize biopharmaceuticals, medical devices, and other health care technologies.

6 May 2010

White House unveils subsidies to preserve early-retiree coverage

A federal program that was authorized in the new health law will help companies pay for as much as $5 billion worth of medical bills of early retirees that they continue to insure, The New York Times reports.

6 May 2010

Scientists use specialized fluorescent protein to study nerve cell activity

Electrical currents are invisible to the naked eye - at least they are when they flow through metal cables. In nerve cells, however, scientists are able to make electrical signals visible. Working with fellow experts from Switzerland and Japan, scientists from the Max Planck Institute for Medical Research in Heidelberg successfully used a specialized fluorescent protein to visualize electrical activity in neurons of living mice.

6 May 2010

Making stem cells in the lab: a training program and a study

Young researchers will now be trained for the first time by the Australian Stem Cell Centre (ASCC) in scientific techniques of using and growing human induced pluripotent stem (iPS) cells in research. This training will be through StemCore iPS Cell Workshop, the ASCC's national facility for the provision of stem cells and advice.

5 May 2010

CPEX Pharmaceuticals reports record quarterly royalty revenues from Testim sales

CPEX Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2010. For the quarter CPEX reported revenues of $5.3 million and a net loss of $940,000.

5 May 2010

CAS Medical Systems reports revenues of $8.5 million for first-quarter 2010

CAS Medical Systems, Inc., today reported first quarter 2010 revenues of $8.5 million, an increase of $0.1 million, or 1%, compared to revenues of $8.4 million for the first quarter of 2009. The Company reported net income of $0.2 million, or $0.02 per basic and diluted common share, compared to a net loss of $0.9 million, or ($0.08) per basic and diluted common share, reported for the first quarter of the prior year.

5 May 2010

BioTime first-quarter total revenue up 159% to $767,127

BioTime, Inc. today reported financial results for the first quarter ended March 31, 2010 and provided an update on recent corporate developments.

5 May 2010

Boehringer Ingelheim, Micromet enter collaboration for new BiTE antibody for multiple myeloma

Boehringer Ingelheim and Micromet, Inc. announced today that they have entered into a collaboration agreement for the research, development and commercialization of a new BiTE antibody for the treatment of multiple myeloma.

5 May 2010